Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer
=================================================================================================================================================================

* Ami N Shah
* Lisa Flaum
* Irene Helenowski
* Cesar A Santa-Maria
* Sarika Jain
* Alfred Rademaker
* Valerie Nelson
* Dean Tsarwhas
* Massimo Cristofanilli
* William Gradishar